Evidence map›Paper›PMID 42436285›Full record

ArticleGenes and immunity2026

Potential role of Akkermansia massiliensis in multiple sclerosis protection by the FcRL3 gene.

Valeria Orrù, Michele Marongiu, Eleonora Cocco, Magdalena Zoledziewska

Abstract read
PubMed Publisher
In one paragraph

Article in Genes and immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Valeria OrrùInstitute of Genetic and Biomedical Research (IRGB), Italian National Research Council (CNR), Cittadella Universitaria Monserrato, Monserrato, Sardinia, Italy.
Michele MarongiuInstitute of Genetic and Biomedical Research (IRGB), Italian National Research Council (CNR), Cittadella Universitaria Monserrato, Monserrato, Sardinia, Italy.
Eleonora CoccoMultiple Sclerosis Center, ASL Cagliari, Italy, Department of Medical Sciences and Public Health, University of Cagliari, Cittadella Universitaria Monserrato, Monserrato, Italy.ORCID http://orcid.org/0000-0002-3878-8820
Magdalena ZoledziewskaInstitute of Genetic and Biomedical Research (IRGB), Italian National Research Council (CNR), Cittadella Universitaria Monserrato, Monserrato, Sardinia, Italy. magdalena.zoledziewska@cnr.it.ORCID http://orcid.org/0000-0002-3033-6133

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The contribution of human genetics in shaping the abundance of gut microbiota is small, about 5%; however, it can inform about disease etiopathogenesis, including multiple sclerosis (MS). Searching for MS-gut microbiota cross-comparison of reported genome-wide association studies (GWAS), we identified a coincident association of the disease with a commensal - Akkermansia massiliensis-in the selective Fc receptor of secretory IgA gene (FcRL3). Those two signals colocalized, supporting that lower abundance of A.massiliensis may contribute to MS predisposition. In cis, the FcRL3-MS predisposing signal downregulates the FcRL3 protein production and modulates the dynamic intron usage between naïve and mature B-cells, which we believe to be the primary molecular mechanism associated with MS risk in this region. The signal also increases the expression of the FcRL5 gene. In trans, it reduces the expression of neuropeptide B/W receptor 1 (NPBWR1) and azurocidin (AZU1), whereas it increases the expression of the tumor necrosis factor receptor superfamily, member 13B (TACI). Our view of MS etiopathogenesis suggests that low levels of FcRL3 and A. massiliensis may predispose to MS by causing impaired self-tolerance to commensal microbiota, dysregulation of B-cell function, and immune system effects on the neuroendocrine signaling by AZU1 and NPBWR1 proteins, which may be further investigated as targets for MS.

Indexed as

AkkermansiaMultiple SclerosisReceptors, ImmunologicAnimalsGenome-Wide Association StudyHumansFCRL3 protein, humanReceptors, Immunologic

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.